Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)
3 Months Ended 6 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Income Statement [Abstract]        
Revenue            
Operating expenses:        
Research and development 557,600 669,300 1,031,200 1,364,800
General and administrative 556,100 545,900 1,353,300 1,150,500
Total operating expenses 1,113,700 1,215,200 2,384,500 2,515,300
Loss from operations (1,113,700) (1,215,200) (2,384,500) (2,515,300)
Other expenses, net:        
Interest expense, net (605,600) (323,200) (1,390,500) (639,600)
Change in warrant liability (1,301,800) (78,600) 425,400 (1,883,500)
Loss on extinguishment of debt (1,603,400)    (2,371,400)   
Loss before income taxes (2,020,900) (1,459,800) (6,571,800) (1,271,400)
Income taxes       2,400 2,700
Net income (loss) (2,020,900) (1,459,800) (6,574,200) (1,274,100)
Basic net loss per share: $ (1.58) $ (1.35) $ (5.24) $ (1.20)
Diluted net loss per share: $ (1.90) $ (1.37) $ (5.24) $ (1.80)
Weighted average shares used in computing basic net loss attributable to common stockholders per common share 1,279,251 1,081,529 1,254,506 1,061,266
Weighted average shares used in computing diluted net loss attributable to common stockholders per common share 1,299,099 1,128,152 1,254,506 1,112,675
Comprehensive income (loss) $ (2,020,900) $ (1,459,800) $ (6,574,200) $ (1,274,100)